BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9522945)

  • 1. Antipyrine pharmacokinetics and urinary excretion in female horses.
    Dyke TM; Sams RA; Hinchcliff KW
    Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of multiple-dose administration of eltenac in horses.
    Dyke TM; Sams RA; Thompson KG; Ashcraft SM
    Am J Vet Res; 1998 Nov; 59(11):1447-50. PubMed ID: 9829405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old.
    Wilcke JR; Crisman MV; Scarratt WK; Sams RA
    Am J Vet Res; 1998 Mar; 59(3):290-2. PubMed ID: 9522947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta.
    Brockmeyer NH; Barthel B; Mertins L; Goos M
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):309-11. PubMed ID: 9660037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF; Gehring R; Hubin M
    J Vet Pharmacol Ther; 2007 Aug; 30(4):314-9. PubMed ID: 17610404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
    Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P
    Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the antipyrine test in laboratory animals. Studies in the dog and monkey.
    Vickers FF; Bowman TA; Dvorchik BH; Passananti GT; Hughes DM; Vesell ES
    Drug Metab Dispos; 1989; 17(2):160-5. PubMed ID: 2565205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.
    Yang BB; Hounslow NJ; Sedman AJ; Forgue ST
    J Clin Pharmacol; 1996 Apr; 36(4):356-60. PubMed ID: 8728350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
    St Peter JV; Abul-Hajj Y; Awni WM
    Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
    Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
    Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
    Coakley M; Peck KE; Taylor TS; Matthews NS; Mealey KL
    Am J Vet Res; 1999 Nov; 60(11):1441-4. PubMed ID: 10566824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sex on antipyrine metabolism in cattle at different ages.
    Janus K; Antoszek J
    J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of short-term water deprivation on antipyrine disposition in calves.
    Janus K; Muszczynski Z; Suszycka J
    Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of flunixin meglumine in healthy foals less than twenty-four hours old.
    Crisman MV; Wilcke JR; Sams RA
    Am J Vet Res; 1996 Dec; 57(12):1759-61. PubMed ID: 8950431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
    Janus K; Muszczynski Z; Suszycka J
    J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.